These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17640515)

  • 21. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
    Moulin G
    Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory considerations for biotechnology-derived animals in Canada.
    Kochhar HP; Adlakha-Hutcheon G; Evans BR
    Rev Sci Tech; 2005 Apr; 24(1):117-25. PubMed ID: 16110882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The organization for economic cooperation and development: challenges for risk assessment.
    McCammon SL
    Environ Biosafety Res; 2006; 5(4):239-43. PubMed ID: 17640517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experiences from the implementation of a biosafety system in Slovenia.
    Milavec M; Racman DS
    Biotechnol J; 2007 Sep; 2(9):1093-104. PubMed ID: 17703486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent development in the field of international liability regimes to tackle environmental risks.
    Bally J
    Water Sci Technol; 2005; 52(6):51-7. PubMed ID: 16304934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OECD international principles for biotechnology safety. A ten year programme for the harmonisation and coordination of safety policies.
    Teso B
    Australas Biotechnol; 1993; 3(2):94-7. PubMed ID: 7763621
    [No Abstract]   [Full Text] [Related]  

  • 27. General principles for risk assessment of living modified organisms: lessons from chemical risk assessment.
    Hill RA; Sendashonga C
    Environ Biosafety Res; 2003; 2(2):81-8. PubMed ID: 15612274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cartagena Protocol on Biosafety: implications for xenotransplantation.
    Kobayashi T; Yamanouchi K
    Xenotransplantation; 2006 Jan; 13(1):10-1. PubMed ID: 16497206
    [No Abstract]   [Full Text] [Related]  

  • 29. History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms.
    Constable A; Jonas D; Cockburn A; Davi A; Edwards G; Hepburn P; Herouet-Guicheney C; Knowles M; Moseley B; Oberdörfer R; Samuels F
    Food Chem Toxicol; 2007 Dec; 45(12):2513-25. PubMed ID: 17692450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of genetically modified organisms (GMOs) in the European Union: principles of risk assessment.
    Anadón A; Roda L; Martínez-Larrañaga MR
    Vet Hum Toxicol; 2004 Dec; 46(6):340-1. PubMed ID: 15587259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cartagena Protocol on Biosafety: interaction between the Convention on Biological Diversity and the World Organisation for Animal Health.
    Sendashonga C; Hill R; Petrini A
    Rev Sci Tech; 2005 Apr; 24(1):19-30. PubMed ID: 16110874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulatory system in europe with special emphasis on allergen products.
    Lorenz AR; Luttkopf D; Seitz R; Vieths S
    Int Arch Allergy Immunol; 2008; 147(4):263-75. PubMed ID: 18648190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of protein safety in the context of agricultural biotechnology.
    Delaney B; Astwood JD; Cunny H; Conn RE; Herouet-Guicheney C; Macintosh S; Meyer LS; Privalle L; Gao Y; Mattsson J; Levine M;
    Food Chem Toxicol; 2008 May; 46 Suppl 2():S71-97. PubMed ID: 18348900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future issues including broadening the scope of the GLP principles.
    Liem FE; Lehr MJ
    Ann Ist Super Sanita; 2008; 44(4):335-40. PubMed ID: 19351991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OECD principles of GLP: what is working and what needs work.
    Viswanathan CT
    Ann Ist Super Sanita; 2008; 44(4):341-3. PubMed ID: 19351992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory considerations on transgenic livestock in Japan in relation to the Cartagena protocol.
    Yamanouchi K
    Theriogenology; 2007 Jan; 67(1):185-7. PubMed ID: 17055568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of the ICRP 2007 recommendations in Korea.
    Cho KW; Kim YM
    Appl Radiat Isot; 2009; 67(7-8):1286-9. PubMed ID: 19299151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quest for harmonisation: differences and similarities in national programmes for GLP monitoring. A senior inspector's viewpoint.
    Helder T
    Ann Ist Super Sanita; 2008; 44(4):331-4. PubMed ID: 19351990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Cartagena protocol and GMOs.
    Pythoud F
    Nat Biotechnol; 2004 Nov; 22(11):1347-8. PubMed ID: 15529146
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety aspects in biotechnology. Classifications and safety precautions for handling of biological agents.
    Frommer W; Krämer P
    Arzneimittelforschung; 1990 Jul; 40(7):837-42. PubMed ID: 2222560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.